Structure of the heterotrimeric complex that regulates type III secretion needle formation
- Manuelle Quinaud*,
- Sophie Plé†,
- Viviana Job*,
- Carlos Contreras-Martel*,
- Jean-Pierre Simorre*,
- Ina Attree†,‡, and
- Andréa Dessen*,‡
- *Institut de Biologie Structurale Jean-Pierre Ebel, 41 Rue Jules Horowitz, Unité Mixte de Recherche 5075, Commissariat à l'Energie Atomique, Centre National de la Recherche Scientifique, Université Joseph Fourier, 38027 Grenoble, France; and
- †Institut de Recherches en Technologie et Sciences pour le Vivant, Unité Mixte de Recherche 5092, Commissariat à l'Energie Atomique, Centre National de la Recherche Scientifique, Université Joseph Fourier, 38054 Grenoble, France
-
Edited by John Kuriyan, University of California, Berkeley, CA, and approved March 21, 2007 (received for review November 14, 2006)
Abstract
Type III secretion systems (T3SS), found in several Gram-negative pathogens, are nanomachines involved in the transport of virulence effectors directly into the cytoplasm of target cells. T3SS are essentially composed of basal membrane-embedded ring-like structures and a hollow needle formed by a single polymerized protein. Within the bacterial cytoplasm, the T3SS needle protein requires two distinct chaperones for stabilization before its secretion, without which the entire T3SS is nonfunctional. The 2.0-Å x-ray crystal structure of the PscE-PscF55–85-PscG heterotrimeric complex from Pseudomonas aeruginosa reveals that the C terminus of the needle protein PscF is engulfed within the hydrophobic groove of the tetratricopeptide-like molecule PscG, indicating that the macromolecular scaffold necessary to stabilize the T3SS needle is totally distinct from chaperoned complexes between pilus- or flagellum-forming molecules. Disruption of specific PscG–PscF interactions leads to impairment of bacterial cytotoxicity toward macrophages, indicating that this essential heterotrimer, which possesses homologs in a wide variety of pathogens, is a unique attractive target for the development of novel antibacterials.
Footnotes
- ‡To whom correspondence may be addressed. E-mail: ina.attree-delic{at}cea.fr or andrea.dessen{at}ibs.fr
-
Author contributions: I.A. and A.D. designed research; M.Q., S.P., V.J., C.C.-M., J.-P.S., I.A., and A.D. performed research; M.Q., V.J., I.A., and A.D. analyzed data; and A.D. wrote the paper.
-
The authors declare no conflict of interest.
-
This article is a PNAS Direct Submission.
-
Data deposition: The atomic coordinates listed in this paper have been deposited in the Protein Data Bank, www.pdb.org (PDB ID code 2UWJ).
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0610098104/DC1.
- Abbreviations:
- T3SS,
- type III secretion systems;
- TPR,
- tetratricopeptide.
- © 2007 by The National Academy of Sciences of the USA





